SEC Form 4 · accession 0000878526-18-000132
NATUS MEDICAL INC · BABY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A Gunst
Director
Period of report
Jul 27, 2018
Accepted (ET)
Jul 31, 2018 · 7:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000878526
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per shareF1 | Jul 27, 2018 | S | 5,000 | $34.17 | D | 54,982 | D | |
| Common Stock, $0.001 par value per share | Jul 27, 2018 | S | 4,100 | $34.03 | D | 50,882 | D | |
| Common Stock, $0.001 par value per share | Jul 31, 2018 | S | 3,240 | $36.00 | D | 47,642 | D | |
| Common Stock, $0.001 par value per share | Jul 31, 2018 | S | 500 | $36.05 | D | 47,142 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $35.15 to $35.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.